Di-n-decyl dimethylammonium bromide, 80% aq. gel, Thermo Scientific Chemicals

Name: Di-n-decyl dimethylammonium bromide, 80% aq. gel, Thermo Scientific Chemicals
SKU: ALFB24832.36

CAS: 2390-68-3 | C22H48BrN | 406.537 g/mol

Change view

Quantity:

500 g

100 g

Catalog number ALFB24832.36

View Price:

Quantity:

500 g

Request bulk or custom format

Specifications

Chemical Name or MaterialDi-n-decyl dimethylammonium bromide

Name Note80% aq. gel

CAS2390-68-3

Health Hazard 1H315-H319

Health Hazard 2GHS H Statement
H315-H319
Causes skin irritation.
Causes serious eye irritation.

Di-n-decyl dimethylammonium bromide is an efficient phase-transfer catalyst useful in many organic reactions. It is useful in many organic transformations such as isomerization, esterification, and alkylation among others.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Di-n-decyl dimethylammonium bromide is an efficient phase-transfer catalyst useful in many organic reactions. It is useful in many organic transformations such as isomerization, esterification, and alkylation among others.

Solubility
Soluble in methanol.

Notes
Incompatible materials are oxidizing agents. Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

RUO – Research Use Only

General References:

C. Carbonea, b, , , , A. Campisic, D. Mannod, A. Serrad, M. Spatuzzae, T. Musumecia, R. Bonfantic, G. Puglisia. The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC. Colloids and Surfaces B: Biointerfaces. 2014, 121, 1-10.
Mei-Hua Qu, Rui-Fang Zeng, Shi Fang, Qiang-Sheng Dai, He-Ping Li, Jian-Ting Long. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. International Journal of Pharmaceutics. 2014, 474, (1-2), 112-122.